MGB-BP-3

• CAT Number: I007978
• CAS Number: 1000277-08-6
• Molecular Formula: C36H37N7O4
• Molecular Weight: 631.73
• Purity: ≥95%
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: 1-methyl-N-[1-methyl-5-(2-morpholin-4-ylethylcarbamoyl)pyrrol-3-yl]-4-[[4-[(E)-2-quinolin-3-ylethenyl]benzoyl]amino]pyrrole-2-carboxamide
• InChI: InChI=1S/C36H37N7O4/c1-41-24-30(20-32(41)35(45)37-13-14-43-15-17-47-18-16-43)40-36(46)33-21-29(23-42(33)2)39-34(44)27-11-9-25(10-12-27)7-8-26-19-28-5-3-4-6-31(28)38-22-26/h3-12,19-24H,13-18H2,1-2H3,(H,37,45)(H,39,44)(H,40,46)/b8-7+
• InChIKey: OEKXCVYZBVOWBR-BQYQJAHWSA-N
• SMILES: CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCN3CCOCC3)C)NC(=O)C4=CC=C(C=C4)C=CC5=CC6=CC=CC=C6N=C5

MGB-BP-3（Cat No.:I007978） is a DNA intercalating drug with potential applications in the treatment of Clostridium difficile infections. It acts by binding to the DNA of the bacteria, disrupting its replication and transcription processes. By targeting the DNA of Clostridium difficile, MGB-BP-3 aims to inhibit bacterial growth and ultimately combat the infection. This drug represents a potential therapeutic option in the fight against Clostridium difficile, a bacterium known to cause severe gastrointestinal infections.